| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT05953480 A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult… |
Trial completed |
| 2026-07-29 | NCT05588323 Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving… |
date change Primary completion pushed: 2026-06-15 -> 2028-06-15 |
| 2026-07-29 | NCT05588323 Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving… |
date change Completion pushed: 2026-06-15 -> 2028-06-15 |
| 2026-07-29 | NCT07214571 A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial… |
Trial sites expanded: 80 -> 83 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-06 | NCT07750990 An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD) | Phase 2 | Not Yet Recruiting |
| 2026-08-05 | NCT07746544 Study of Secutrelvir in Participants With COVID-19 | Phase 3 | Not Yet Recruiting |
| 2026-08-04 | NCT07743580 A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07743580 | A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are… | SARS-CoV-2 | Not Yet Recruiting |
| NCT07746544 | Study of Secutrelvir in Participants With COVID-19 | COVID-19 | Not Yet Recruiting |
| Phase 2 | |||
| NCT07123155 | Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With… | Pompe Disease | Recruiting |
| NCT07214571 | A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial… | Respiratory Syncytial Virus Infections | Recruiting |
| NCT06776432 | Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea | Sleep Apnea | Active, Not Recruiting |
| NCT06717438 | Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder… | Jordan's Syndrome | Active, Not Recruiting |
| NCT07750990 | An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD) | Pompe Disease | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05101070 | S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in… | Solid Tumors | Recruiting |
| NCT05588323 | Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving… | Opioid-Induced Constipation (OIC) | Recruiting |
| Phase 1 | |||
| NCT07093580 | Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants | Healthy Participants | Recruiting |